Marsh & McLennan, US5717481023

Marsh & McLennan stock (US5717481023): Recent earnings beat and market position

14.05.2026 - 14:55:23 | ad-hoc-news.de

Marsh & McLennan reported strong quarterly results, beating EPS expectations with $3.29 versus $3.21 anticipated and revenue up 7.6% year-over-year, per recent data.

Marsh & McLennan, US5717481023
Marsh & McLennan, US5717481023

Marsh & McLennan Companies recently delivered quarterly results that exceeded analyst expectations. Earnings per share came in at $3.29, topping the $3.21 forecast, while revenue grew 7.6% year-over-year, according to MarketBeat as of May 2026. The stock closed at $158.98, down 2.70% that day on NYSE.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: Marsh & McLennan Companies
  • Sector/industry: Insurance brokerage and professional services
  • Headquarters/country: United States
  • Core markets: Global, with strong US presence
  • Key revenue drivers: Risk management, insurance brokerage, consulting
  • Home exchange/listing venue: NYSE (MRSH)
  • Trading currency: USD

Official source

For first-hand information on Marsh & McLennan, visit the company’s official website.

Go to the official website

Marsh & McLennan: core business model

Marsh & McLennan operates as a global professional services firm, focusing on insurance brokerage, risk management, and consulting. Its key subsidiaries include Marsh, which handles insurance broking; Guy Carpenter for reinsurance; Mercer for consulting; and Oliver Wyman for strategy advice. This diversified model serves clients worldwide, helping businesses navigate risk, strategy, and human capital challenges, according to company descriptions on official site as of May 2026.

The company generates revenue primarily through commissions, fees, and consulting services. In recent quarters, it has emphasized growth in high-margin areas like risk advisory amid volatile global markets.

Main revenue and product drivers for Marsh & McLennan

Insurance brokerage remains the largest revenue driver, with Marsh leading placements for commercial and specialty risks. Revenue growth has been supported by 7.6% year-over-year increases in recent reports. Consulting via Mercer contributes through retirement, health, and talent strategies, appealing to US corporations.

Key products include cyber risk solutions and climate-related insurance, reflecting sector demands. The stock traded at $158.98 USD on NYSE as of recent close, per MarketBeat as of May 2026.

Industry trends and competitive position

The insurance brokerage sector faces rising premiums due to catastrophe losses and cyber threats, benefiting incumbents like Marsh & McLennan. It holds a leading position with extensive global reach, particularly relevant for US investors via NYSE listing and exposure to the world's largest insurance market.

Why Marsh & McLennan matters for US investors

As a NYSE-listed firm headquartered in New York, Marsh & McLennan offers US investors access to stable, fee-based revenues tied to the US economy's risk management needs. Its role in advising Fortune 500 firms underscores its market relevance.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

Marsh & McLennan continues to demonstrate resilience with earnings beats and steady revenue growth in a competitive sector. Recent quarterly performance highlights its operational strength, while market cap stood at £56.43 billion as of May 2026 per CompaniesMarketCap as of May 2026. Investors track its adaptation to emerging risks.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis Marsh & McLennan Aktien ein!

<b>So schätzen die Börsenprofis  Marsh &amp; McLennan Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US5717481023 | MARSH & MCLENNAN | boerse | 69334220 | bgmi